Product was successfully added to your shopping cart.

LEDIKAST - Ledipasvir 90 mg and Sofosbuvir 400 mg Tablets

Be the first to review this product

Quick Overview

LEDIKAST Tablets Specification :

Brand Name : LEDIKAST
Contents: Ledipasvir and Sofosbuvir
Marketed by : Aprazer Health Care
Manufactured by : Natco Pharma Limited
Strength - Each film-coated tablet Contains : 90 mg Ledipasvir and 400 mg Sofosbuvir
Form : Tablets
Packing : Pack of 28 Tablets

Colors: Yellow oxide of Iron, Titanium Dioxide IP and FD&C Blue#2

Ledikast is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase.

Availability: In stock